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Until  recently, interferon  (IFN) x has been  viewed primarily  as an antiviral  agent 
that  activates enzymes to interfere with viral  replication  in host cells  (1).  Its impor- 
tance,  however,  might  lie  beyond  this  direct  activation  of viral  resistance  because 
increasing  evidence  points  to  IFN  as  a  regulator  of a  multitude  of cell-mediated 
immune  responses  (2).  This  property  of IFN as well  as its  ability  to inhibit  certain 
tumor  cells  in  culture  has  been  the  basis  for  the  current  interest  in  its  use  in  the 
therapy of cancer patients. One of its key immunoregulatory functions is its ability to 
augment natural  killer  (NK) cell activity, which may well be an essential part of the 
early  defense  mechanism  against  infections  or  tumor  development  (3).  The  cells 
responsible  for NK activity exist in circulation  in man for most of his adult  life  (3), 
and a recent study showed similar results in mice, when peripheral blood lymphocytes 
(PBL) instead of spleen cells were used as the source of NK cells  (4). 
All classes of IFN (5-7), including recombinant IFN produced in Escherichia  coli (8), 
are  effective  in  augmenting  NK activity.  Analysis with  metabolic  inhibitors  of the 
mechanism of the NK augmentation process indicated  the need for a  short period of 
RNA and protein synthesis after contact with IFN (9,  10) and it seems likely that new 
production  of receptors  for  target  cells  and/or  lytic  enzymes  is  important  in  the 
boosting of reactivity.  In addition to IFN, a  variety of biological agents can enhance 
cytotoxicity in NK cells  (11-14).  These agents presumably perform this  function by 
inducing  IFN, but  the cell  sources of such  IFN are unclear.  Virus-infected  cells  are 
extremely  sensitive  to  NK lysis,  and  this  sensitivity  might  be  due,  in  part,  to  IFN 
induced in the infected cells and/or in the effector cell population  (15-17).  There is 
some  evidence  that  human  NK  cells  can  produce  IFN  during  contact  with  K562 
tumor cells  (18).  However, their IFN-producing capabilities  to other substances have 
not yet been explored. 
The  present  study  was  designed  to  determine  whether  human  NK  cells  could 
produce  IFN  in  response  to  viruses,  such  as  influenza  and  herpes  simplex,  and 
1  Abbreviations used in this paper."  FBS,  fetal bovine serum; IFN, interferon; LGL, large granular lympho- 
cytes; NK, natural killer, PBL, peripheral blood lymphocytes; PBS, phosphate-buffered saline. 
1222  Journal of Experimental Medicine • Volume 156, October 1982  1222-1234 DJEU,  STOCKS, ZOON,  STANTON, TIMONEN,  AND HERBERMAN  1223 
subsequently become augmented in their lytic function. We also considered the ability 
of other cell types to provide helper function, either by IFN production themselves or 
by  proper  presentation  of the  virus  to  the  IFN-producing cell, thus  aiding  in  the 
augmentation  sequence.  This  aspect  was  worth  investigating  because  of previous 
reports that influenza virus can induce IFN in monocytes (19)  and that Sendai virus 
might induce IFN in B  cells (20), whereas HSV-1  has been shown  to induce IFN in 
Fc receptor-negative null cells (21). We demonstrate that large granular lymphocytes 
(LGL), which possess virtually all of the NK activity and comprise ~  10% of the total 
PBL  (22), can produce IFN of either e~ or y  type in response to influenza virus, and 
the  type  induced  may  depend  on  the  donor's  previous  encounter  with  the  virus. 
Herpes simplex, on  the other hand,  induced mainly IFN-a production  by LGL.  In 
parallel with  IFN production,  enhanced  NK  activity was  seen  in  LGL  in  all cases 
after incubation with the viruses, suggesting positive self regulation of function. 
Materials  and  Methods 
Viruses.  Influenza  A/Port  Chalmers/1/73  (H3N2)  virus,  originally obtained  from  Dr. 
Geoffrey Schild, National Institute for Biological Standards and Control, Hampstead, England, 
was prepared by inoculation in fertile hens' eggs (23).  Herpes simplex  1 (HSV-1), Rodanus 
strain,  was  prepared by inoculation into Vero cell cultures  (24).  Both  viruses were  kindly 
provided by Martha Wells, Food and  Drug Administration, Bureau  of Biologics, Bethesda, 
MD. 
Peripheral Blood Lymphocytes.  Lymphocytes were obtained from three sources, all located at 
the  National  Institutes of Health,  Bethesda,  MD.  The  lymphocyte concentrates  from  the 
Platelet-Pheresis Center were diluted 1:5 in RPMI  1640 medium containing 10% fetal bovine 
serum (FBS), 100/xg/ml each of penicillin and streptomycin, 2 mM glutamine, 5 mM Hepes, 
and  2  U/ml  of preservative-free heparin.  The  buffy  coats  from  the  blood  bank  and  the 
leukopacks from the leukopheresis center were diluted 1:2 in phosphate-buffered saline (PBS). 
PBL were then prepared from the three types of blood preparations by centrifugation on Ficoll- 
Hypaque at 400 g for 30 min at room temperature. 
Discontinuous Percoll Density  Gradient Centrifugation.  The separation of LGL, which are large 
lymphocytes with  kidney-shaped nuclei  and  azurophilic cytoplasmic granules  from  small 
mature T  cells, was accomplished by the use of a discontinuous Percoll density gradient (18). 
An essential step before the gradient centrifugation was the rigorous removal of adherent cells 
that tended to band in the lighter fractions close to those of LGL. More than 99% removal of 
adherent cells was achieved by incubation of the PBL obtained after Ficoll-Hypaque centrifu- 
gation on plastic petri dishes (3003;  Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, 
CA) or tissue culture flasks (Costar Data Packaging, Cambridge, MA 3275) for 2 h at 37°C and 
a further incubation on nylon columns for 30 min at 37°C. The cells passing through the nylon 
columns were then placed on a seven-step discontinuous Percoll density gradient that varied in 
2.5% concentrations from 40-55%, as has previously been described in detail elsewhere (25). 
Constant osmolarity of the Percoll solution and the dilution medium (285  mosmol/kg H20) 
was critical for the successful separation of LGL from the rest of the cells. After centrifugation 
at 550 g for 30 min at room temperature, the bands of lymphocytes were collected and checked 
for LGL morphology on Giemsa-stained cytocentrifuged slides. In this series of experiments, 
fraction  3  contained  70-90%  LGL,  and  fractions  6-7  contained  295%  OKT3 +  T  cells. 
Monocytes/macrophages were recovered by gentle scraping of the petri dish-adherent cells with 
a rubber policeman. 
Culture Conditions  for the Induction of lFN and Augmentation of NK Activity.  Based on preliminary 
experiments that determined the optimum concentrations of viruses and cells, the following 
procedure was adopted for routine use. The cultures were carried out in RPMI  1640 medium 
containing  1% FBS,  100 #g/ml penicillin and streptomycin 2 mM  L-glutamine, and 5  mM 
Hepes. 2 million cells from each of the Percoll fractions as well as an aliquot taken from the 
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medium alone or with a virus, in a final volume of 1.0 ml in 24-well plates  (Costar 3524;  Data 
Packaging)  for  18  h  at  37°C.  The  final concentrations  of influenza A/PC  and  HSV-1  were 
1:1,000  and  1:100  of the stock solutions,  respectively.  In  addition  to  these cell cultures,  an 
aliquot of each of the subpopulations was placed in medium and kept in the refrigerator for the 
same length of time, to provide baseline activities. In most experiments, this 4°C control did 
not differ from the medium control at 37°C and, therefore, those results are not reported. 
At the end of the incubation, the supernatants from all the cultures were collected and frozen 
at -70°C  or immediately tested for the content of IFN. Additional controls were included in 
preliminary experiments, in which the viruses were incubated  in the absence of lymphocytes, 
and  the supernatants  were collected for the detection  of IFN.  These controls were necessary 
because of the possibility that the viruses might induce IFN production in the human fibroblast 
test  cells  during  the  IFN  titrations,  thus,  giving  false  positive  results.  However,  the  virus 
supernatants  were consistently negative in the IFN assay. After collection of the supernatants, 
the cells were harvested  and  transferred  to 96-well microtiter plates  for mesasurement  of NK 
activity. 
Removal of T Cells.  To eliminate contaminating T  cells from the LGL fractions, 0.2 ml of a 
1:4 dilution of OKT3 (Ortho Pharmaceutical,  Raritan, N J) was added to 1 ×  10 7 lymphocytes 
in 0.1 ml of medium. The mixture was kept on ice for 30 min before addition of 0.1 ml of a  1:4 
dilution of rabbit complement (Gibco Laboratories, Grand Island Biological Co., Grand Island, 
NY). After further incubation for 45 min at 37°C in a shaking water bath, the cells were washed 
and resuspended to 4 ×  106 cells/ml. No correction of the viability was done, so that the original 
number  of cells  that  could  produce  IFN  or  be  boosted  could  be  retained.  Medium  and 
complement  controls  from  the same  fractions  were  included  in  most  of the experiments.  In 
addition,  to check for the efficiency of the procedure for removal of T  cells, an aliquot of the 
nonadherent  input cells that contained a  large proportion of T  cells as well as an aliquot of T 
cells from  fraction  7 were similarly treated,  with  the appropriate  medium  and  complement 
controls. Cell viability was then checked on all samples. 
Removal of B Cells.  The procedure was identical to that mentioned above for OKT3, except 
that that the antibody used was goat anti-IgM (N. L. Cappel Laboratories, Cochranville, PA), 
and  0.1  ml  of the  undiluted  reconstituted  serum  was  added  to  1  ×  10  7  lymphocytes  (26). 
Because nylon wool-passed nonadherent  cells were virtually free of B cells, additional controls 
consisting of whole unseparated  PBL were included to check for the proper elimination of B 
cells. Cell viability was determined in all samples after the various treatments. 
Inactivation of  Monocytes.  Contaminating monocytes in the LGL preparations were inactivated 
by incubation with silica or carrageenan at final concentrations of 200/lg/ml,  100/~g/ml or 50 
~g/ml for 2 h  at 37°C (27). 
Titration of IFN.  The  levels of IFN  in  the  culture  supernatants  were  determined  by  the 
inhibition of cytopathic effect by vesicular stomatitis virus in human  foreskin fibroblasts when 
performed at the Bureau of Biologics (28)  and by Sindbis virus in human WISH amniotic cells 
when performed at the University of Texas (26). The titers are expressed in international units, 
standardized  with NIH reference human  leukocyte IFN (G-023-901-527). 
Neutralization of IFN.  Anti-IFN-a, prepared by K. Zoon in sheep against an  18,000 mol wt 
component of lymphoblastoid IFN, had a titer of 900,000 U/ml (28).  Sheep anti-IFN-a, kindly 
provided by Dr. B.  Dalton and  Dr. C. A. Ogburn,  had a  titer of 640,000  U/ml  (29).  Rabbit 
anti-IFN-fl, kindly provided by Dr.  Y.  K.  Yip and  Dr. J.  Vilcek (30),  had  a  titer of 1:6,000, 
whereas sheep anti-IFN-fl, obtained from Dr. B. Dalton and Dr. C. A. Ogburn,  had a  titer of 
1:60,000.  Rabbit anti-IFN--/, as previously described (31), had a  titer of 1:6,000. 
Qualitative identification of IFN in the culture supernatants  was performed by incubating 
each IFN sample with 10-100-fold excess of antiserum of each type for 1 h at room temperature. 
In some experiments, two or more antisera were added to determine the presence of a  mixture 
of IFN  species.  The  IFN/anti-IFN  mixture  was  then  diluted  serially  at  half-log  dilutions 
through  six wells of a  96-well microtiter plate. These dilutions were then transferred  to wells 
containing  human  fibroblasts  or  WISH  cells  for  determination  of  residual  IFN  activity. 
Laboratory standards of IFN-a, fl, y were included in each assay. 
Measurement of NK Activity.  NK activity was determined by the release of radioactivity from 
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effector/target ratios of 50:1 and 10:1 in a 96-well microtiter plate (25). The supernatants were 
collected by the Titertek harvesting system  (Flow Laboratories,  McLean,  VA).  The baseline 
(autologous)  lysis was determined by the addition of unlabeled autologous tumor cells to the 
labeled targets at the same ratios as lymphocytes to target cells. Percent NK activity was then 
calculated  as  follows:  ([experimental  epm  -  autologous  cpm]/[total  cpm  incorporation])  × 
100. 
The autologous control was usually 6-8%, and the standard error in most groups was <1%. 
Percent cytotoxicity of >2.0% was usually significantly different from the control at P  <  0.05. 
For clarity in presenting data in Results, the standard errors were not included, and percent 
eytotoxicity <1% was expressed as 0% in all cases. 
Results 
Induction  of IFN and  Boosting  of NK  Activity  in  Cell  Fractions Recovered from  Percoll 
Gradients.  Results of initial studies to define the cell population(s) that responded to 
influenza  A/PC  and  HSV-1  are  shown  in  Fig.  1.  The  fractions  incubated  with 
medium alone showed the typical profile of distribution of spontaneous NK activity, 
with  peak  activities  in  fractions  2-3,  in  which  70-90%  of the  cells  showed  LGL 
morphology on cytocentrifuged slides. The denser cells, particularly in fractions 5-7, 
which  consisted  mainly of small  lymphocytes with  the characteristics  of mature T 
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FIG.  1.  Augmentation of NK  activity  and  induction  of IFN  in  lymphocytes  fractionated  by 
discontinuous  Percoll  gradients.  Each  lymphocyte  fraction  was  incubated  with  medium  (O), 
influenza A/PC virus (i), or HSV-1 ((3) for 18 h at 37°C before they were tested for production of 
IFN and for augmentation of NK activity at a  10/1 effector/target ratio. 1226  VIRAL INDUCTION OF INTERFERON  IN HUMAN  LYMPHOCYTES 
nonadherent input cells showed IFN production and boosted NK activity. After these 
cells were  fractionated  according  to  density,  only  the  LGL-enriched  fractions  2-3, 
which  initially contained  spontaneous  NK  activity, responded  by  IFN production. 
The  level  of  IFN  detected  was  remarkably  high,  particularly  in  LGL  cultures 
containing influenza A/PC.  As expected, NK  activity was  also augmented  in  these 
same  fractions.  There  was  no  quantitative  correlation  between  the  level  of  IFN 
production  and the degree of augmentation  of NK activity, suggesting (as has been 
previously reported)  (5) that small amounts of IFN may suffice to produce maximum 
cytotoxicity. IFN was  also detected in  fraction  1,  which was probably produced  by 
monocytes,  as will be seen  in  more  detail in  experiments  to  be  discussed below.  A 
consistent observation was  the lack of IFN production  or boosted cytotoxicity in T 
cells of fractions 5-7. 
Kinetics of IFN Production and Boosting of NK Activity.  The lack of a  T  cell response 
might  have been  due  to insufficient time of incubation  with  the viruses.  Moreover, 
proper presentation of the virus by adherent accessory cells might have been necessary 
for stimulation of T  cells. To rule out these possibilities, LGL from fraction 3 and T 
cells from fractions 6-7 were cultured in the absence or presence of 10% monocytes for 
1-4  d,  with  optimum  doses  of  influenza  A/PC  or  HSV-1.  In  parallel,  adherent 
monocytes, either at the 10% level or at a  10-fold higher concentration, were incubated 
with viruses (Table I). Again, the LGL responded to both viruses by IFN production 
and  augmented  cytotoxicity, and  peak  levels were  observed  by day  I.  Addition of 
monocytes did not enhance either function, although monocytes were also capable of 
producing IFN. It is interesting to note that  monocytes, at the concentration added 
to provide helper function or at the 10-fold higher concentration, still did not produce 
the  levels  of IFN  production  seen  with  LGL.  T  cells  showed  no  response  in  the 
presence of monocytes, even  after 4  d  of culture.  The  low levels of IFN seen in  the 
mixture  of  T  cells  and  monocytes  can  be  accounted  for  by  production  by  the 
monocytes alone. 
Elimination of Contaminating T  Cells from  LGL.  Although small mature T  cells were 
not  involved in IFN production  under  the conditions of our assay, other T  cells of 
TABLE  1 
Kinetics of IFN Induction and Enhancement of NK Activity by Viruses 
Virus  Days of 
culture 
Percent cytotoxicity (units of IFN/ml)* 
LGL  T cells  Monocytes{ 
Without  Without  With 10%  With 10%  mnno-  10%  100%  monocytes  monocytes  monocytes  cytes 
None  1  15.3 (0)  12.4 (0)  0 (0)  0 (0)  0 (0)  0 (0) 
Influenza A/PC  29.6 (3,125)  25.1 (3,125)  0 (0)  0 (200)  0 (125)  0 (625) 
Herpes simplex 1  30.9 (1,250)  25.5 (1,220)  0 (0)  0 (125)  0 (125)  0 (250) 
None  4  18.7 (0)  11.3 (0)  0 (0)  0 (0)  0 (0)  0 (0) 
Influenza A/PC  28.8 (2,000)  24.6 (3,125)  0 (0)  0 (200)  0 (200)  0 (625) 
Herpes simplex 1  28.3 (1,250)  23.2 (1,250)  0 (0)  0 (200)  0 (250)  0 (400) 
* Effector/target  ratio of 10/1. 
:~ Monocytes were incubated with each virus at the concentration  that represented  10% (2 x  105 cells/ml) 
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medium size that could contaminate the LGL fractions might serve as the source. To 
eliminate  this  possibility,  LGL and  the  nonadherent  input  ceils  were  both  treated 
with OKT3 plus complement before incubation with influenza A/PC  or HSV-1. As 
seen in Table II, this treatment eliminated  75% of the input cells,  100% of the cells in 
fraction  7, and 25% in the LGL-containing fraction.  (In other experiments,  10-40% 
of the LGL fractions were killed,  depending on the purity of the samples. This level 
of OKT3-positive  cells  is  often  seen  in  LGL  fractions  that  have  not  been  further 
fractionated  with  29 °  E  rosetting).  The  treated  LGL  were  still  as  potent  as  the 
medium  or  complement  control  cells  in  producing  IFN  and  exhibiting  enhanced 
cytotoxicity. The input  fraction,  when  treated  with  OKT3  plus  C,  often  produced 
low levels of IFN, (~25 U) in the absence of either virus. This low level might be due 
to the IFN-inducing capability of OKT3 itself on T  cells. An accompanying enhance- 
ment of NK activity was also seen. 
Elimination of Contaminating Monocytes from  LGL.  Because  LGL-enriched  fractions 
contain  small  percentages  of monocytes,  it  was  necessary  to  further  eliminate  the 
possibility  that  some  monocytes contaminating  the  LGL fractions might  have  pro- 
vided  helper  function  or  served  as  the  IFN  source.  Therefore,  the  LGL-enriched 
fractions were incubated with silica or carrageenan for 2 h  at 37°C and then cultured 
with  influenza  A/PC  or  HSV-1.  Monocytes  alone  were  also  treated  in  a  similar 
fashion,  to monitor the efficacy of the  monocyte-toxic agents.  As seen  in Table III, 
monocytes produced  125 U  and 50 U/ml  of IFN with influenza A/PC  and  HSV-1, 
but this function was lost after treatment with  100-200/~g/ml of silica or 200 #g/ml 
of carrageenan. Of interest was the ability of silica to inhibit NK activity in LGL but 
not IFN production, when used at 200 #g/ml.  Silica at lower doses and carrageenan 
at all doses used did not interfere with either of the functions of LGL. 
Further proof of the ability of LGL alone to respond to viruses was provided by the 
simultaneous treatment of LGL with OKT3 plus complement and silica (Table IV). 
Removal of both T  ceils and monocytes from LGL had no effect on the IFN-producing 
capability or the enhancement of cytotoxicity. 
Elimination ofContarninating B CeUsfrorn LGL.  The input cells used in the fraction- 
ation procedure had first been passed through nylon wool, which is highly efficient in 
removing B  cells.  Because  there  have been some reports  that  B  cells  are capable of 
producing IFN, particularly to Sendai virus (20)  or to heterologous tumor cells  (26), 
we examined the possibility of a  small amount of contamination of LGL with B ceils 
TABLE II 
Effect of OKT3 plus Complement on IFN Production and Enhancement of Cytotoxicity in LGL 
Cell population*  Treatment  Viability 
Percent cytotoxicity (units of IFN/ml):~ 
Influenza  Herpes  None  A/PC  simplex 1 
Nonadherent  Medium  98%  17.5 (0)  27.1 (625)  25.4 (125) 
OKT3 + C  25%  32.1 (25)  33.9 (1,000)  29.5 (125) 
C  99%  11.4 ((3)  29.3 (625)  28.4 (125) 
LGL  Medium  98%  28.7 (0)  40.3 (2,000)  43.8 (625) 
OKT3 + C  74%  25.6 (0)  33.1 (2,000)  36.2 (625) 
* Fraction 7, containing virtually 100% T cells, showed 0% viability after treatment with OKT3 + C. 
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TABLE  III 
Effect of Monocyte-Toxic  Agents on IFN Production and Enhancement  of Cytotoxicity  in LGL 
Concen  -  Cell population  Treatment  tration 
Percent cytotoxicity (units of IFN/ml)* 




Medium  --  0  (0)  0  (125)  0  (50) 
Silica  200  0  (0)  0  (0)  0  (0) 
Silica  100  0  (0)  0  (0)  0  (0) 
Silica  50  0  (0)  0  (50)  0  (40) 
Carrageenan  200  0  (0)  0  (0)  0  (0) 
Carrageenan  100  0  (0)  0  (0)  0  (0) 
Carrageenan  50  0  (0)  0  (125)  0  (50) 
Medium  --  17.3 (0)  27.6 (1,250)  28. i  (250) 
Silica  200  2.7  (0)  2.0 (1,250)  1.8 (250) 
SiIica  I00  13.8 (0)  24.5 (I,000)  28.5 (250) 
Silica  50  14.0 (0)  23.9 (1,250)  26.7  (200) 
Carrageenan  200  15.4 (0)  29.6 (1,000)  26.8 (250) 
Carrageenan  100  14.2 (0)  30.9 (1,250)  29.5 (250) 
Carrageenan  50  14.8 (0)  28.4 (1,250)  26.4 (250) 
*Effector/target ratio of 10/1. 
TABLE  IV 
Effect of Removal of both OKT3 +  Cells and Monocytes on IFN Production and Enhancement  of 
Cytotoxicity in LGL 
Concen-  Cell population  Treatment  tration 
Percent cytotoxicity (units of IFN/ml)* 




Medium  --  0  (0)  0  (200)  0  (50) 
SiIica  200  0  (0)  0  (0)  0  (13) 
Silica  100  0  (0)  0  (0)  0  (0) 
Medium  --  32.7 (0)  44.7 (3,125)  43.8  (1,000) 
Silica  200  1.2 (0)  0  (3,125)  0  (0) 
Silica  100  28.4 (0)  38.5 (3,125)  37.6 (1,250) 
OKT3 +  C  --  32.9 (0)  38.1 (3,125)  42.2  (1,250) 
OKT3 + C/silica  200  0  (0)  0  (3,125)  0  (1,000) 
OKT3 + C/silica  100  29.5 (0)  40.7 (2,000)  39.8 (1,000) 
* Effector/target ratio of 10/1. 
that  might contribute  to IFN production.  LGL  were thus treated with anti-IgM  plus 
complement,  before incubation  with  the  viruses.  Table  V  shows  that  ~20%  of PBL 
but  <1%  of nylon wool-passed  cells and  <1%  of LGL  were  killed by this  treatment. 
The treated cells showed unimpaired  IFN production  and  enhanced  NK  activity. 
Characterization  of  IFN.  Antigenic  typing  of  the  IFN  produced  by  LGL  and 
monocytes in response in influenza A/PC  and  HSV-1  was performed in two separate 
laboratories,  at  the  University of Texas  (Table  VI)  and  at  the  Bureau  of Biologics 
(Table VII), using different sources of antisera prepared  against  IFN a, fl, and 7. The 
data  from both  laboratories  were comparable  and  showed  that  the IFN  produced  in 
LGL or monocytes in most cases was readily neutralized  by anti-a  and  not by anti-fl DJEU,  STOCKS,  ZOON,  STANTON,  TIMONEN,  AND  HERBERMAN  1229 
TABLE  V 
Effect of Anti-IgMplus Complement  on IFN Production and Enhancement of Cytotoxicity in LGL 
Cell population  Treatment  Viability 
Percent cytotoxicity (units of IFN/ml)* 
Influenza  Herpes  None  A/PC  simplex  1 
Unseparated PBL  Medium  99%  5.5 (0)  12.3  (200)  14.3  (125) 
Anti-IgM +  C  78%  8.6 (0)  15.4  (250)  14.8 (125) 
C  98%  6.2 (0)  14.9 (250)  13.3  (100) 
Nonadherent  Medium  98%  12.6 (0)  19.1  (250)  20.1  (50) 
Anti-IgM +  C  99%  11.5  (0)  19.3  (125)  19.5  (50) 
C  99%  11.8  (0)  20.2 (125)  18.8  (40) 
LGL  Medium  99%  28.1  (0)  35.9 (400)  37.7 (250) 
Anti-IgM +  C  98%  26.3 (0)  46.4 (625)  36.1  (125) 
* Effector/target ratio of 10/1. 
TABLE  VI 
Neutralization of IFN Induced in LGL and Monocytes by Influenza and HSV-1  Viruses 
Residual IFN activity after treatment  with* 
Source of IFN  Day of  Stimulus  anti-a  anti-a  anti-fl  anti-a, fl 
culture  Me- 
dium  anti-a*  anti-B:~  anti-7~  and  and  and  and 
anti-fl  anti-'/  anti-y  anti- y 
LGL  1  A/PC  3,000  <10  3,000  3,000  <10  <10  3,000  <10 
HSV  3,000  <10  3,000  3,000  <10  <10  3,000  <10 
4  A/PC  3,000  <10  3,000  3,000  <10  <10  3,000  <10 
HSV  3,000  <10  3,000  3,000  <10  <10  3,000  <10 
Monocytes  1  A/PC  3,000  <10  3,000  3,000  <10  <10  3,000  <10 
HSV  100  <10  100  <10  <10  100  <10 
Standard  6,000  <100  6,000  6,000  NDII  ND  ND  ND 
IFN-a 
Standard  3,000  1,000  100  6,000  ND  ND  ND  ND 
IFN-fl 
Standard  6,000  6,000  6,000  <100  ND  ND  ND  ND 
IFN-y 
* Undiluted cell culture supernates were preincubated with each antiserum for 1 h at room temperature  before they were titered for IFN on 
WISH cells challenged with Sindbis virus. 
J~ Anti-~x  and fl were obtained from Dr. B. Dalton and Dr. C. A. Ogburn. 
§ Anti-y was prepared by G. J. Stanton and colleagues. 
[[ Not done. 
and anti-,/. In some individuals, however, their LGL responded to influenza A/PC by 
producing IFN that was not neutralized by anti-a or anti-fl, but completely by anti- 
T, as shown in Table VII. Further analysis of one of these individuals showed that he 
was seropositive to influenza A/PC. 
Discussion 
Recently  available  techniques  using  discontinuous  Percoll  density  centrifugation 
for isolation of human LGL, which are primarily responsible for NK function in PBL, 
have enabled us to examine the NK-IFN system in detail. In particular, we have been 
able to direct our research to answer the questions:  (a) whether IFN may be produced 
by  LGL  in  response  to  inducers  such  as  viruses;  (b)  whether  helper  cells  may  be 
required for optimum IFN production in LGL;  (c) whether other classes of lymphoid 
cells  may produce  virally-induced  IFN;  (d)  whether IFN  can  activate  non-LGL  to 1230  VIRAL INDUCTION OF INTERFERON  IN HUMAN LYMPHOCYTES 
TABLE  VII 
Comparison of lFN Induced in Cells from Donors Seropositive and Seronegative to Influenza 
Donor  Source of IFN  Stimulus  Day of  culture 
Residual IFN activity after treatment 
with* 
Medium  Anti-a*  Anti-fl§  Anti-3'll 
Seronegative to A/PC  LGL 
Monocytes 
A/PC  1  250  <5  250  250 
HSV-1  250  <5  250  250 
A/PC  4  250  <5  250  250 
HSV-1  250  <5  250  200 
A/PC  1  200  <5  200  200 
HSV-1  125  <5  125  125 
Seropositive  to A/PC  LGL 
Monocytes 
A/PC  1  250  250  250  <5 
HSV- 1  200  <5  200  200 
A/PC  4  250  250  250  <5 
HSV- 1  250  <5  250  250 
A/PC  1  250  <5  250  250 
HSV-1  125  <5  125  125 
Standard  500  <5  500  500 
IFN-a 
Standard  500  500  <5  500 
IFN-fl 
Standard  250  250  250  <5 
IFN-3, 
* Cell culture supernatants  diluted to an initial concentration of 125-250  IFN U/ml were preincubated 
with each antiserum for  1 h at room temperature before they were titered for IFN on human foreskin 
fibroblasts  challenged with vesicular stomatitis virus. 
:~ Anti-a serum was prepared by K. Zoon and colleagues. 
§ Anti-fl serum was obtained from Dr. Y. K. Yip and Dr. J. Vilcek. 
II Anti-3' serum was prepared by G. J. Stanton and colleagues. 
acquire NK  function;  and  (e)  whether  more than  one species of IFN  can be induced 
in a  single subset of lymphoid cells. The results presented here showed that  LGL were 
remarkably  well-equipped  to  respond  to  influenza  and  HSV-1.  The  response  was 
twofold:  a  rapid  induction  of IFN and  a  parallel enhancement  of NK  activity.  Peak 
levels of IFN,  ~  1  ×  10  a U/106 cells, were induced  within  24 h  of exposure  to either 
virus, and  addition  of monocytes to the cultures  did not enhance  IFN  production  or 
raise NK levels further. Other lymphocyte fractions isolated from the Percoll gradient, 
which  made  up  90%  of the  input  nonadherent  cells,  exhibited  neither  IFN  nor  NK 
function in the absence  or presence of viruses.  We considered  the possibility that  the 
failure to observe some response  in these non-LGL  fractions  might have been due to 
either of two factors  (a)  a  slower kinetics in  the production  of IFN;  or  (b)  the lack of 
a  helper population.  However, incubation  for up to 4  d, with or without  the addition 
of monocytes,  did not alter the pattern,  and  no IFN or lyric activity was observed  in 
the small T  cell fractions. 
On  the  other  hand,  monocytes  responded  to  the  viruses  by  IFN  production,  but 
they  did  not  acquire  the  ability  to  lyse  K562  target  cells.  The  levels  of IFN  were 
usually  below  those  produced  in  LGL.  The  ability  of monocytes  to  produce  IFN 
during overnight culture with influenza virus has been described earlier (19), and our 
data are consistent with that previous report. It is interesting to note the IFN produced DJEU, STOCKS, ZOON, STANTON, TIMONEN, AND HERBERMAN  1231 
in leukocytes on a large scale for clinical trials are virally induced and might in large 
part be a product of LGL, with only a smaller contribution from monocytes. 
The purity of the LGL population was critical for definitive identification of these 
ceils as the source of viral-induced IFN. To leave little doubt about the capability of 
LGL to produce IFN, the  LGL fractions were subjected  to further purification  by 
removal of contaminating T  cells, monocytes, and B  cells.  Removal of T  cells from 
the LGL by monoclonal OKT-3 plus complement had no effect on IFN production 
or enhancement of NK activity. Similarly, incubation of LGL with 100/.tg/ml of silica 
or  various  concentrations  of carrageenan,  which  inactivated  monocytes,  did  not 
interfere  with  the  two  functions.  Of interest  was  that  higher  levels of silica  could 
inhibit spontaneous NK activity in LGL, but their IFN-producing capability was not 
blocked. This result might explain previous in vivo observations of potent inhibition 
by silica of NK activity in mice (32).  It might represent a direct sublethal toxic effect 
of silica on NK cells rather than the elimination of monocytes that are required  for 
the maintenance of in vivo NK activity. Simultaneous treatment of LGL with OKT3 
plus complement and silica provided further proof of the ability of LGL to function 
alone in response to viruses. 
Analysis of the antigenic characteristics of the IFN induced  by the viruses with a 
battery of antisera against IFN a, fl, and 3, showed that LGL and monocytes, in most 
individuals, produced IFN-a to both viruses. However, the LGL of a  individual with 
detectable serum antibodies against influenza A/PC, indicating previous exposure to 
the virus, produced  IFN-y. This is consistent  with  the recent  report of Ennis  et al. 
(33),  who  used  unfractionated  PBL  from  volunteers  who  were  vaccinated  with 
influenza. Our results are also in line with those of Greene et al.  (34), who observed 
only  IFN-a  in  HSV-seronegative  individuals  but  IFNa  and  IFNy in  seropositive 
individuals when their PBL were stimulated with  HSV-1.  A  surprising finding was 
the high levels of IFN-a, and particularly of IFN-T, from LGL cultured with influenza 
A/PC. We routinely detected  1,000  U/106 LGL and at times obtained 10,000-15,000 
U/10  n LGL, similar to the findings of Ennis et al.  (33), suggesting that this might be 
an  efficient  means  of producing  IFN-), in  quantities  large  enough  for research  or 
clinical  purposes.  The  other  quite  intriguing  aspect  of  this  suggestion  of  IFN-), 
production by LGL is that it provides an indication  for a  specific-immune function 
by these cells, which have been considered by us and some other investigators to be 
within the T  cell lineage. 
The observation that LGL responded to influenza and HSV-1 by IFN production 
is an important finding because of the implication that NK cells are under positive 
self-regulation, being able to produce IFN that can in turn activate cytolytic function 
of these cells. The efficiency of the NK cell system is reflected in their apparent lack 
of a  requirement  for helper cells of another cell type, either for the IFN production 
stage  or  for  the  activation  of  the  lytic  mechanism.  A  second  finding  of  equal 
importance  was  the  lack  of augmentation  of cytotoxicity  in  T  cells,  even  in  the 
presence of monocytes that can provide IFN as the boosting agent.  IFN appears to 
enhance  cytolytic function  only in  LGL, indicating  that  IFN-activatable precursor 
NK cells do not exist in non-LGL fractions. There has been some suggestive evidence 
that the human cell type that produced IFN on exposure to virus-induced tumor cells 
was  the  same  as  the  cytotoxic  effector cell  (12).  Our  results  now  firmly establish 
human  LGL  as  the  source  of both  virus-induced  IFN  production  as  well  as  NK 1232  VIRAL  INDUCTION OF INTERFERON IN HUMAN LYMPHOCYTES 
activity. These  findings  mirror observations made in  the  mouse that  IFN and  NK 
activity are confined to the same set  of Ly5  +, Qa5  +,  asialo GM1  + spleen  cells  (17). 
However, it remains to be determined whether the same subpopulations of LGL with 
NK activity also are responsible for the IFN production in response to viruses. 
Our data do not indicate whether there is a  recruitment of new NK cells  from an 
inactive population in the LGL fraction or whether cytolytic activity is enhanced in 
already active  NK cells.  Minato  et  al.,  in  the  mouse,  have shown  a  conversion of 
precursor NK to the active state  (17).  In the human, Targan and Dorey (35)  as well 
as Timonen et  al.  (36) have shown that  both recruitment  of new effector cells  and 
activation of lytic function take place. Timonen et al.  (36),  in particular, have shown 
in  great  detail  that  the  two  phenomena  occur  in  the  LGL  population.  Future 
experiments with cloned LGL cultures should provide a  better insight into the exact 
mechanism of NK augmentation. 
Another aspect  of considerable interest  in  the present  findings was the ability of 
LGL to produce more than  one type of IFN.  It would be  of interest  to determine 
whether the different types of IFN are made by separate subpopulations or whether, 
depending on the nature of and previous exposure to the stimulus, the same cells can 
produce different IFN species.  In any event, these data strengthen the suggestion that 
NK cells might be important in natural resistance to various microorganisms, partic- 
ularly in the early stage of infection. 
Summary 
Augmentation  of natural  killer  (NK)  activity  by  influenza  A/PC  and  HSV-1 
viruses appears to be caused by the induction of interferon (IFN) within the NK cell 
population itself. These viruses induced high levels of IFN production by human large 
granular lymphocytes (LGL) that could be readily isolated from peripheral blood by 
Percoll density gradients. These LGL, which have been previously shown to account 
for and to be highly associated with endogenous NK activity, became augmented in 
their lytic function during the  18-h  period that  IFN was induced.  Non-LGL helper 
cells  did not appear to be required in the NK-IFN system (either T  cells,  B cells,  or 
monocytes). Removal of these latter cell types by treatment with OKT3 plus comple- 
ment, anti-IgM plus complement, or preincubation with silica or carrageenan had no 
effect on the ability of LGL to respond to the  viruses.  Production of IFN was also 
detected, albeit at lower levels,  from monocytes cultured for 18 h with viruses, but no 
cytotoxic activity was induced.  On the other hand, T  cells,  even in the presence of 
monocytes, showed neither property, and longer cultures, with virus up to 4 d, still 
did  not  alter  the  pattern.  The  IFN produced  by both  LGL  and  monocytes were 
predominantly IFN-a, as  assessed  by neutralization  assays with  antisera  to  IFN-cL 
-iS, and  -y.  In  an  individual  with  detectable  serum  antibodies  to  influenza  A/PC, 
however, the IFN induced in LGL appeared to be T, presumably because of specific 
recognition  of  the  virus.  These  data  suggest  an  efficient  positive  self-regulatory 
mechanism in NK cells that may be readily switched on by viruses. 
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